Sustained incobotulinumtoxinA (Xeomin) efficacy in upper limb poststroke spasticity over 48 weeks in A phase 3, placebo-controlled study with an open-label extension. (25th December 2016) - Kaňovský, Petr; Brashear, Allison; Elovic, Elie P.; Munin, Michael C.; Hanschmann, Angelika; Hiersemenzel, Reinhard; Marciniak, Christina